Finance

Beta
Lists
500126:BOM
Procter & Gamble Health Ltd
₹6,210.00
+0.14%
(+8.95) 1D
Jun 9, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500126...
Open
₹6,155.65
High
₹6,259.00
Low
₹6,155.65
Mkt. cap
102.92B
Avg. vol.
2.04K
Volume
445.00
Dividend
2.50%
Quarterly dividend
₹38.75
Ex-dividend date
Aug 21, 2026
P/E ratio
31.53
52-wk high
₹6,701.40
52-wk low
₹4,699.70
EPS
₹196.94
No. of employees
1K
Open
₹6,155.65
High
₹6,259.00
Low
₹6,155.65
Mkt. cap
102.92B
Avg. vol.
2.04K
Volume
445.00
Dividend
2.50%
Quarterly dividend
₹38.75
Ex-dividend date
Aug 21, 2026
P/E ratio
31.53
52-wk high
₹6,701.40
52-wk low
₹4,699.70
EPS
₹196.94
No. of employees
1K
News stories
From sources across the web
About Procter & Gamble Health Ltd
CEO-
Employees1.33K
Founded1967
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.39B
3.25B
3.74B
3.70B
Cost of goods sold
939.90M
684.00M
1.10B
928.70M
Cost of revenue
939.90M
684.00M
1.10B
928.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
560.10M
538.80M
618.10M
508.60M
Operating expense
1.60B
1.42B
1.59B
1.48B
Total operating expenses
2.54B
2.11B
2.69B
2.41B
Operating income
849.00M
1.14B
1.05B
1.29B
Other non operating income
40.30M
49.50M
43.60M
40.00M
EBT including unusual items
888.10M
1.19B
1.09B
1.33B
EBT excluding unusual items
888.10M
1.19B
1.09B
1.33B
Income tax expense
226.30M
304.80M
312.30M
386.10M
Effective tax rate
25.48%
25.61%
28.70%
28.98%
Other operating expenses
984.00M
823.70M
917.70M
911.30M
Net income
661.80M
885.40M
775.90M
946.00M
Net profit margin
19.54%
27.25%
20.75%
25.54%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.20M
-1.20M
-1.00M
-2.10M
Net interest expenses
-1.20M
-1.20M
-1.00M
-2.10M
Depreciation and amortization charges
54.40M
60.80M
59.00M
61.70M
EBITDA
903.40M
1.20B
1.09B
1.35B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more